SearchSearch results for: “”

Stibbe represented the director and sole shareholder of the Royal Brinkers group of companies in a insolvency litigation matter. In 2010, the majority of entities within the Royal Brinkers group went bankrupt as a result of changed market conditions.

Stibbe represented North Sea Port Netherlands N.V in Supreme Court proceedings against Glencore AG concerning a right of pledge.

On 27 July 2015, Teva Pharmaceutical Industries announced that it has withdrawn its previously announced hostile bid to acquire Mylan N.V. Stibbe represented Mylan in this successful takeover defence and advised Mylan on both litigation and EU competition

Assisting the State of Malta with regard to the alleged failure of Malta to fulfill its obligations under the Birds Directive.

Stibbe advises a company in the chemical industry on a regulation case about safety standards.

Advising a transport organisation on the implementation of new regulation standards.

Advising a financial organisation how to avoid the publication of a sanction imposed by the regulator.

Representing the Belgian Ministry of Economy in a high-profile lawsuit against SABAM (the Belgian Society of Authors, Composers and Publishers) before the Brussels courts concerning the private collecting society’s compliance with the Belgian Copyright Ac

Providing legal assistance to several companies with regard to investigations of the Social Affairs and Employment Inspectorate (SAE, in Dutch: Inspectie Sociale Zaken en Werkgelegenheid) and imposed fines under the Foreign Nationals (Employment) Act. 

Stibbe assisted a consortium composed of Belgacom, T-Systems International GmbH, Strabag AG, and Efkon AG with the preparation of its bid and with the negotiations and subsequent closing of the contract for the realization of the ETCS PPR project.

Stibbe advised Akzo Nobel in an action before the General Court to prevent the European Commission from publishing information originating from leniency documents.

Succesfully defended Ballast Nedam and Royal BAM in legal proceedings against the Province of Groningen regarding the "Blauwe Stad" (Blue City).

Stibbe advises Intermixt as the representative of the Flemish municipalities of the so-called mixed energy distribution sector with respect to the withdrawal of Electrabel from the Flemish electricity and gas distribution system operators.

Stibbe advises Mylan Inc., the pharmaceuticals company listed on the NASDAQ with a market cap of approximately $19 billion, on the inversion acquisition of Abbott’s non-U.S. developed markets specialty and branded generics business.

Stibbe advises Zeeland Seaports in relation to the demolishing and decommissioning of a large phosphorus plant in Vlissingen. The plant, including its buildings, installations and the ground underneath, is highly contaminated with phosphorus, asbestos and